RGEN - Repligen Corporation
| Previous Close | 57.68 |
| Open | 58.04 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's Range | 56.80 - 58.17 |
| 52 Week Range | 29.56 - 58.99 |
| Volume | 323,669 |
| Avg. Volume | 321,115 |
| Market Cap | 2.489B |
| Beta | 1.44 |
| PE Ratio (TTM) | 109.08 |
| EPS (TTM) | 0.52 |
| Earnings Date | Nov 7, 2018 - Nov 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53.43 |
Markit•6 days agoSee what the IHS Markit Score report has to say about Repligen Corp.
Repligen Corp NASDAQ/NGS:RGEN
- GlobeNewswire•last month
Recent Analysis Shows STMicroelectronics N.V, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen, and RealNetworks Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Aug. 22, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STMicroelectronics ...
Markit•last monthSee what the IHS Markit Score report has to say about Repligen Corp.
Repligen Corp NASDAQ/NGS:RGEN
Markit•last monthSee what the IHS Markit Score report has to say about Repligen Corp.
Repligen Corp NASDAQ/NGS:RGEN
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of RGEN earnings conference call or presentation 2-Aug-18 12:30pm GMT
Q2 2018 Repligen Corp Earnings Call
- Zacks•2 months ago
Repligen (RGEN) Misses Q2 Earnings Estimates
Repligen (RGEN) delivered earnings and revenue surprises of -11.11% and 3.62%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
Repligen: 2Q Earnings Snapshot
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 6 cents. Earnings, adjusted for one-time gains and costs, were 16 cents per share. The results did not meet Wall ...
- GlobeNewswire•2 months ago
Repligen Reports Second Quarter 2018 Financial Results
Record quarterly revenue of $47.7 million represents 47% year-over-year growth Revenue guidance raised to $185-$190 million for full year 2018 WALTHAM, Mass., Aug. 02, 2018-- Repligen Corporation, a life ...
- ACCESSWIRE•2 months ago
Repligen Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 2, 2018 / Repligen Corporation (NASDAQ: RGEN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 8:30 AM Eastern Time. ...
- ACCESSWIRE•2 months ago
Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Repligen
NEW YORK, NY / ACCESSWIRE / August 1, 2018 / Wall Street snapped its losing streak on Tuesday as investors digested better-than-expected quarterly earnings and after the Trump administration appeared to ...
Markit•2 months agoSee what the IHS Markit Score report has to say about Repligen Corp.
Repligen Corp NASDAQ/NGS:RGEN
- GlobeNewswire•2 months ago
Repligen to Report Second Quarter 2018 Financial Results
WALTHAM, Mass., July 19, 2018-- Repligen Corporation today announced that the Company will report its second quarter of 2018 financial results on Thursday, August 2, 2018. The Company will issue a press ...
Markit•3 months agoSee what the IHS Markit Score report has to say about Repligen Corp.
This means that investors who seek to profit from falling equity prices are currently targeting RGEN. Over the last month, growth of ETFs holding RGEN is favorable, with net inflows of $9.18 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
- PR Newswire•3 months ago
Purolite Life Sciences Announces the Launch of Praesto® Jetted A50 Using Proprietary Jetting Technology - Leading the Future of Protein A Chromatography Resins
In multiple successive trials, Praesto® Jetted A50 has consistently shown significantly improved performance over today's market leading Protein A resins, due to the unique benefits of an innovative new ligand coupled to a novel jetted base matrix.
- GlobeNewswire•3 months ago
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an agreement with Purolite Life Sciences to supply its next-generation Protein A ligand, NGL-Impact™ A, which will be commercialized by Purolite Life Sciences using their novel Praesto® agarose jetting base bead technology. Repligen is a longtime market leader in Protein A, with two facilities that produce the majority of the global Protein A ligand demand to biopharmaceutical customers worldwide. NGL-Impact™ A was developed as part of Repligen’s collaboration with Navigo Proteins GmbH.
- GlobeNewswire•3 months ago
Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands
Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. Under the terms of this agreement, Repligen and Navigo will co-develop a portfolio of next generation ligands, utilizing Navigo’s proprietary Precision Capturing™ technology platform.
- Zacks•4 months ago
Moving Average Crossover Alert: Repligen (RGEN)
Repligen Corporation (RGEN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of RGEN earnings conference call or presentation 8-May-18 12:30pm GMT
Q1 2018 Repligen Corp Earnings Call
- Associated Press•4 months ago
Repligen: 1Q Earnings Snapshot
The Waltham, Massachusetts-based company said it had profit of 8 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 17 cents per share. The results exceeded Wall Street ...
Yahoo Finance Video•3 months agoCVS will offer home delivery of prescriptions
In an effort to stave off Amazon, CVS will roll-out nationwide delivery of prescription medication. Yahoo Finance's Seana Smith, Ethan Wolff-Mann, David Pogue and Rick Newman discuss.
